Srivorakun Hataichanok, Singha Kritsada, Fucharoen Goonnapa, Fucharoen Supan
a Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences , Khon Kaen University , Khon Kaen , Thailand.
Hematology. 2018 Apr;23(3):187-191. doi: 10.1080/10245332.2017.1380930. Epub 2017 Sep 25.
To report the hematological and molecular features as well as diagnostic aspects of the hitherto un-described interactions of two rare α-globin chain variants with α-thalassemia commonly found among Southeast Asian populations.
The study was done on two adult Thai patients (P1 and P2) who had hypochromic microcytic anemia. Hb analysis was carried out using high performance liquid chromatography (HPLC) and capillary electrophoresis (CE). Mutations were identified by PCR and related techniques.
Hb analysis of P1 using HPLC showed a normal Hb pattern, but CE demonstrated an abnormal peak at zone 7. DNA sequencing identified a CCG-CTG mutation at codon 95 of the α2 globin gene corresponding to the Hb G-Georgia [α95(G2)Pro → Leu(α2)] previously undescribed in the Thai population. In contrast, Hb analysis of P2 demonstrated an abnormal peak not fully separated from Hb A on HPLC, but not on CE. DNA analysis identified the rarely described Hb Nakhon Ratchasima [α63(E12)Ala → Val(α2)] mutation. Routine DNA analysis detected the SEA deletion α-thalassemia in trans to the Hb variants in both cases. Hematological parameters were compared with those of patients with compound heterozygote for other α-globin variants and α-thalassemia previously documented.
Identification of the patients confirmed that interaction of these rare Hb variants with α-thalassemia does not lead to the Hb H disease. Differentiation of these two Hb variants from other clinically relevant hemoglobinopathies in a routine setting is, however, necessary. This can be accomplished using a combined Hb-HPLC and CE analysis followed by PCR-RFLP assays.
报告两种罕见的α-珠蛋白链变异体与东南亚人群中常见的α-地中海贫血之间迄今未描述的相互作用的血液学和分子特征以及诊断方面。
对两名患有低色素小细胞贫血的成年泰国患者(P1和P2)进行了研究。使用高效液相色谱法(HPLC)和毛细管电泳法(CE)进行血红蛋白分析。通过聚合酶链反应(PCR)及相关技术鉴定突变。
使用HPLC对P1进行的血红蛋白分析显示血红蛋白模式正常,但CE显示在区域7有一个异常峰。DNA测序在α2珠蛋白基因的第95密码子处鉴定出CCG-CTG突变,对应于泰国人群中先前未描述的血红蛋白G-佐治亚州[α95(G2)Pro→Leu(α2)]。相比之下,对P2的血红蛋白分析显示在HPLC上有一个异常峰,未与血红蛋白A完全分离,但在CE上没有。DNA分析鉴定出罕见的血红蛋白呵叻[α63(E12)Ala→Val(α2)]突变。常规DNA分析在两例病例中均检测到与血红蛋白变异体呈反式的SEA缺失型α-地中海贫血。将血液学参数与先前记录的其他α-珠蛋白变异体和α-地中海贫血的复合杂合子患者的参数进行了比较。
对这些患者的鉴定证实,这些罕见的血红蛋白变异体与α-地中海贫血的相互作用不会导致血红蛋白H病。然而,在常规情况下将这两种血红蛋白变异体与其他临床相关血红蛋白病区分开来是必要的。这可以通过联合使用血红蛋白-HPLC和CE分析,随后进行PCR-RFLP检测来实现。